We’re thrilled to welcome Gavin, Elizabeth and Adrienne to their new leadership roles at this important time for both Bioclinica and the industry and where our teams are making a real difference in the lives of patients around the world.
Princeton, NJ (PRWEB) April 11, 2018
Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, today announces two executive-level additions and one promotion, further strengthening and diversifying its executive leadership team. Joining Bioclinica are Gavin Nichols as Chief Information Officer & Executive Vice President, Technology, and Elizabeth Edwards as President, Bioclinica Site Network, and a member of the executive management team. Additionally, Adrienne Rossi is promoted to the newly created position, Chief of Staff. All three will report to President & CEO David Herron.
“I’m pleased to have such talented life science professionals like Gavin, Elizabeth and Adrienne on our leadership team as we move toward continued growth, success and innovation,” said David Herron. “Each will work across our dynamic organization, driving significant value creation for our biopharmaceutical and CRO clients across our Medical Imaging, Technology and Site Network businesses.”
As Chief Information Officer & Executive Vice President, Technology, Gavin Nichols will lead the planning and execution of the Company’s long-term information technology vision. He will be responsible for delivering scalable business applications and technology solutions. “I’m excited to head Bioclinica’s technology organization, known for best-in-class clinical applications and robust cloud infrastructure,” said Nichols. He has over 25 years of experience both as an executive IT professional and general manager and has led global technology teams in delivering analytics, recruitment, wearables, electronic health records, genetics, consumer apps and trial management solutions. He established and led the co-development of a service organization to improve clinical planning and trial design for an industry-leading sponsor. He was instrumental in the creation of Quintiles’ (now IQVIA) Infosario technology suite, and prior to this was with Unisys where he grew a new $100 million practice. Nichols has a Bachelor’s degree in Computer Science from Open University (UK) and an MBA from Bournemouth University (UK). Nichols, who relocated from United Kingdom to the U.S. 12 years ago, is based in the Durham, North Carolina office.
As President, Bioclinica Site Network, Elizabeth Edwards leads a network of sites located across the U.S., Europe, Latin America and Asia. She also directs Bioclinica’s Patient Recruitment services. An accomplished executive in pharmaceutical research and development, Edwards has contributed substantially to numerous drug approvals in a range of therapeutic areas. Previously she was with global CRO Chiltern International where she led a 1,000+ member team in advancing sponsors’ Oncology clinical research programs. Previously, she was with Novella Clinical and Inspire Pharmaceuticals. She also founded and managed a successful clinical development consulting firm, Edwards Pharmaceutical Research. Early in her career she was a clinical research scientist assigned to GSK studies. Edwards has a Bachelor’s degree in Pre-Medicine, Psychology from the University of Virginia. Edwards, who is based in Raleigh, said, “I’m proud to lead Bioclinica’s exceptionally skilled and patient-centered Site Network team, which is making significant contributions to research in Alzheimer’s, Arthritis, Central Nervous System and many other diseases.
As Chief of Staff, Adrienne Rossi will work closely with the CEO as she leads and executes on the organization’s strategic initiatives and aligns resources and processes across the enterprise. She will be responsible for managing staff globally, overseeing financial and top administrative operations and will collaborate with other top executives in shaping the Company’s future. She has 20 years of industry experience, including 15 with Bioclinica. Rossi most recently served as Vice President of Business Transformation for the Medical Imaging service line. “Being with Bioclinica during a period of historic growth and innovation has been a tremendous experience and I look forward to continuing to build on this in my new role,” said Rossi. She has extensive experience in clinical trials both operationally and in project management across many therapeutic areas. Early in her career she was a clinical study manager for ophthalmic clinical studies at Bausch & Lomb. Rossi has a Bachelor’s degree in Public Health and Women's Studies from Rutgers University.
Herron commented, “We’re thrilled to welcome Gavin, Elizabeth and Adrienne to their new leadership roles at this important time for both Bioclinica and the industry and where our teams are making a real difference in the lives of patients around the world.”
Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe and Asia.